| Date | Form | Description | Docs | XBRL | Pages |
| 01/16/07 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 | |
| 01/31/06 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/17/06 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 04/22/05 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 | |
| 01/18/05 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
51 | |
| 01/18/05 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/18/05 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 12/22/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
51 | |
| 02/13/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
49 | |
| 01/29/03 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 |
Latest News & Events
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Read More...Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences to Host an Investor Webcast on June 26, 2025
Read More...